Osaic Holdings’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $384K | Buy |
16,978
+5,058
| +42% | +$112K | ﹤0.01% | 3608 |
|
|
2025
Q4 | $308K | Buy |
11,920
+9,652
| +426% | +$230K | ﹤0.01% | 3786 |
|
|
2025
Q3 | $60.3K | Sell |
2,268
-45
| -2% | -$1.1K | ﹤0.01% | 5191 |
|
|
2025
Q2 | $55.3K | Buy |
2,313
+49
| +2% | +$1.24K | ﹤0.01% | 4976 |
|
|
2025
Q1 | $56.3K | Buy |
2,264
+1,117
| +97% | +$26.7K | ﹤0.01% | 4627 |
|
|
2024
Q4 | $21.6K | Buy |
1,147
+407
| +55% | +$7.15K | ﹤0.01% | 5287 |
|
|
2024
Q3 | $11.1K | Sell |
740
-926
| -56% | -$15.8K | ﹤0.01% | 5759 |
|
|
2024
Q2 | $47.7K | Sell |
1,666
-1,080
| -39% | -$30.7K | ﹤0.01% | 4716 |
|
|
2024
Q1 | $80.2K | Sell |
2,746
-2,536
| -48% | -$77.9K | ﹤0.01% | 4399 |
|
|
2023
Q4 | $178K | Sell |
5,282
-676
| -11% | -$19.8K | ﹤0.01% | 4021 |
|
|
2023
Q3 | $183K | Buy |
5,958
+482
| +9% | +$17.4K | ﹤0.01% | 4060 |
|
|
2023
Q2 | $219K | Sell |
5,476
-524
| -9% | -$21.7K | ﹤0.01% | 3822 |
|
|
2023
Q1 | $245K | Sell |
6,000
-9,636
| -62% | -$383K | ﹤0.01% | 3710 |
|
|
2022
Q4 | $604K | Sell |
15,636
-719
| -4% | -$35K | ﹤0.01% | 2858 |
|
|
2022
Q3 | $868K | Buy |
16,355
+550
| +3% | +$30.6K | ﹤0.01% | 2366 |
|
|
2022
Q2 | $922K | Sell |
15,805
-7,310
| -32% | -$479K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $1.76M | Buy |
23,115
+6,625
| +40% | +$442K | ﹤0.01% | 2032 |
|
|
2021
Q4 | $993K | Buy |
16,490
+10,191
| +162% | +$562K | ﹤0.01% | 2413 |
|
|
2021
Q3 | $353K | Buy |
6,299
+509
| +9% | +$29.3K | ﹤0.01% | 3383 |
|
|
2021
Q2 | $354K | Sell |
5,790
-50
| -0.9% | -$3.17K | ﹤0.01% | 3361 |
|
|
2021
Q1 | $410K | Sell |
5,840
-144
| -2% | -$10.3K | ﹤0.01% | 3088 |
|
|
2020
Q4 | $359K | Sell |
5,984
-122
| -2% | -$7.14K | ﹤0.01% | 2948 |
|
|
2020
Q3 | $367K | Buy |
6,106
+1,590
| +35% | +$92.4K | ﹤0.01% | 2712 |
|
|
2020
Q2 | $234K | Buy |
4,516
+509
| +13% | +$21.3K | ﹤0.01% | 2986 |
|
|
2020
Q1 | $135K | Buy |
+4,007
| New | +$166K | ﹤0.01% | 3229 |
|
Other funds holding PCRX
DPCM
VPM
VCM
